Article
Diosgenin Inhibits Prostate Cancer Progression by Inducing UHRF1 Protein Degradation
2022-05-12
Abstract excerpt
<h4>Background: </h4> and Purpose: Aberrant overexpression of UHRF1 has been reported in several cancer types and UHRF1 is regarded as a novel drug target for cancer therapy. However, no UHRF1-targeted specific small compound inhibitor has been registered in clinical trials. Experimental Approach: Network pharmacology together with molecular docking were used to screened a natural molecule bank for PCa treatment....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8873950d-e8c9-5ba6-9fd0-e516aeab3c63
- DOI
- 10.22541/au.165237524.42526501/v1
